Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Publisher Correction to: C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation

Publisher Correction to: C11orf95-RELA fusion drives aberrant gene expression through the unique... Ozawa et al. acta neuropathol commun (2021) 9:100 https://doi.org/10.1186/s40478-021-01157-y Open Access PUBLISHER CORREC TION Publisher Correction to: C11orf95‑RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation 1*† 2*† 3 4 1,5 Tatsuya Ozawa , Syuzo Kaneko , Frank Szulzewsky , Zhiwei Qiao , Mutsumi Takadera , 6 4 3,7 2,8 1* Yoshitaka Narita , Tadashi Kondo , Eric C. Holland , Ryuji Hamamoto and Koichi Ichimura Center Research Institute, Chuo‑ku, Tokyo 104‑0045, Japan. Department Correction to: Ozawa et  al. acta neuropathol commun of Neurosurgery, Yokohama City University, Yokohama, Kanagawa 236‑0027, (2021) 9:36 https:// doi. org/ 10. 1186/ s40478- 021- 01135-4 Japan. Department of Neurosurgery and Neuro‑Oncology, National Cancer In the original publication of the article [1] there were 7 Center Hospital, Chuo‑ku, Tokyo 104‑0045, Japan. Seattle Tumor Trans‑ errors introduced during the publication process involv- lational Research Center, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA. RIKEN Center for Advanced ing the italic emphasis. These errors are as followed: Intelligence Project, Cancer Translational Research Team, 1‑4‑1 Nihonbashi, Chuo‑ku, Tokyo 103‑0027, Japan. FUS • The italicized terms of “RELA ” have been amended as this was erroneously applied to the genes and proteins. Author details Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Chuo‑ku, Tokyo 104‑0045, Japan. Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Chuo‑ku, Tokyo 104‑0045, Japan. Human Biology Division, Fred Hutchin‑ son Cancer Research Center, 1100 Fairview Avenue North, Mailstop C3‑168, Seattle, WA 98109, USA. Division of Rare Cancer Research, National Cancer The original article can be found online at https:// doi. org/ 10. 1186/ s40478‑ 021‑ 01135‑4. *Correspondence: taozawa@ncc.go.jp; sykaneko@ncc.go.jp; kichimur@ncc. go.jp Tatsuya Ozawa and Syuzo Kaneko contributed equally to this work Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Chuo‑ku, Tokyo 104‑0045, Japan Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Chuo‑ku, Tokyo 104‑0045, Japan Full list of author information is available at the end of the article © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://crea‑ tivecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdo‑ main/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. Ozawa et al. acta neuropathol commun (2021) 9:100 Page 2 of 2 Reference Publisher’s Note 1. Ozawa T, Kaneko S, Szulzewsky F et al (2021) C11orf95-RELA fusion drives Springer Nature remains neutral with regard to jurisdictional claims in pub‑ aberrant gene expression through the unique epigenetic regulation for lished maps and institutional affiliations. ependymoma formation. Acta Neuropathol Commun 9:36. https:// doi. org/ 10. 1186/ s40478‑ 021‑ 01135‑4 Re Read ady y to to submit y submit your our re researc search h ? Choose BMC and benefit fr ? Choose BMC and benefit from om: : fast, convenient online submission thorough peer review by experienced researchers in your field rapid publication on acceptance support for research data, including large and complex data types • gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over 100M website views per year At BMC, research is always in progress. Learn more biomedcentral.com/submissions http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Neuropathologica Communications Springer Journals

Publisher Correction to: C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation

Loading next page...
 
/lp/springer-journals/publisher-correction-to-c11orf95-rela-fusion-drives-aberrant-gene-LMuSvflVRX

References (1)

Publisher
Springer Journals
Copyright
Copyright © The Author(s) 2021
eISSN
2051-5960
DOI
10.1186/s40478-021-01157-y
Publisher site
See Article on Publisher Site

Abstract

Ozawa et al. acta neuropathol commun (2021) 9:100 https://doi.org/10.1186/s40478-021-01157-y Open Access PUBLISHER CORREC TION Publisher Correction to: C11orf95‑RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation 1*† 2*† 3 4 1,5 Tatsuya Ozawa , Syuzo Kaneko , Frank Szulzewsky , Zhiwei Qiao , Mutsumi Takadera , 6 4 3,7 2,8 1* Yoshitaka Narita , Tadashi Kondo , Eric C. Holland , Ryuji Hamamoto and Koichi Ichimura Center Research Institute, Chuo‑ku, Tokyo 104‑0045, Japan. Department Correction to: Ozawa et  al. acta neuropathol commun of Neurosurgery, Yokohama City University, Yokohama, Kanagawa 236‑0027, (2021) 9:36 https:// doi. org/ 10. 1186/ s40478- 021- 01135-4 Japan. Department of Neurosurgery and Neuro‑Oncology, National Cancer In the original publication of the article [1] there were 7 Center Hospital, Chuo‑ku, Tokyo 104‑0045, Japan. Seattle Tumor Trans‑ errors introduced during the publication process involv- lational Research Center, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA. RIKEN Center for Advanced ing the italic emphasis. These errors are as followed: Intelligence Project, Cancer Translational Research Team, 1‑4‑1 Nihonbashi, Chuo‑ku, Tokyo 103‑0027, Japan. FUS • The italicized terms of “RELA ” have been amended as this was erroneously applied to the genes and proteins. Author details Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Chuo‑ku, Tokyo 104‑0045, Japan. Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Chuo‑ku, Tokyo 104‑0045, Japan. Human Biology Division, Fred Hutchin‑ son Cancer Research Center, 1100 Fairview Avenue North, Mailstop C3‑168, Seattle, WA 98109, USA. Division of Rare Cancer Research, National Cancer The original article can be found online at https:// doi. org/ 10. 1186/ s40478‑ 021‑ 01135‑4. *Correspondence: taozawa@ncc.go.jp; sykaneko@ncc.go.jp; kichimur@ncc. go.jp Tatsuya Ozawa and Syuzo Kaneko contributed equally to this work Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Chuo‑ku, Tokyo 104‑0045, Japan Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Chuo‑ku, Tokyo 104‑0045, Japan Full list of author information is available at the end of the article © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://crea‑ tivecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdo‑ main/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. Ozawa et al. acta neuropathol commun (2021) 9:100 Page 2 of 2 Reference Publisher’s Note 1. Ozawa T, Kaneko S, Szulzewsky F et al (2021) C11orf95-RELA fusion drives Springer Nature remains neutral with regard to jurisdictional claims in pub‑ aberrant gene expression through the unique epigenetic regulation for lished maps and institutional affiliations. ependymoma formation. Acta Neuropathol Commun 9:36. https:// doi. org/ 10. 1186/ s40478‑ 021‑ 01135‑4 Re Read ady y to to submit y submit your our re researc search h ? Choose BMC and benefit fr ? Choose BMC and benefit from om: : fast, convenient online submission thorough peer review by experienced researchers in your field rapid publication on acceptance support for research data, including large and complex data types • gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over 100M website views per year At BMC, research is always in progress. Learn more biomedcentral.com/submissions

Journal

Acta Neuropathologica CommunicationsSpringer Journals

Published: May 27, 2021

There are no references for this article.